This trial is active, not recruiting.

Condition regional anesthesia
Treatments nerve block washout, sham washout, saline
Sponsor University of Alberta
Start date February 2014
End date December 2015
Trial size 40 participants
Trial identifier NCT02050295, Pro00044120


Injecting local anesthetic to anesthetize a nerve or group of nerves (a 'nerve block') is an effective way to eliminate pain during and after surgery. There are instances when it would be beneficial to the patient for the nerve block to be resolved quickly rather than waiting for it to naturally wear off. For example, a sciatic nerve block that freezes the lower leg and foot typically takes over 18 hours to resolve on its own, and both the surgeon and patient prefer to have motor function before discharge. The investigators wish to perform a randomized, controlled trial to determine if infusion of a solution such as saline to 'wash out' the nerve block after surgery can allow the patient to be pain-free while still being able to move their leg and foot.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking double blind (subject, outcomes assessor)
Primary purpose treatment
Patients will receive a washout infusion of saline through their perineural catheter to reverse their motor block while maintaining the sensory block.
nerve block washout
Saline will be infused through the perineural catheter to reverse motor block.
saline Normal saline
(Sham Comparator)
Patients will receive an infusion of saline run just enough to maintain catheter patency.
sham washout
Infusion of saline to maintain catheter patency.
saline Normal saline

Primary Outcomes

Motor function
time frame: Within 72 hours post-surgery

Secondary Outcomes

Sensory function
time frame: Within 72 hours post-surgery
time frame: Within 72 hours post-surgery
Patient satisfaction
time frame: Within 72 hours post-surgery
Time to first oral analgesic
time frame: Within 72 hours post-surgery

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Provide informed written consent - Adult (≥ 18 years old) patients - Scheduled for lower extremity surgery wholly or partially under popliteal sciatic nerve block Exclusion Criteria: - Failure to provide informed consent - Infection at the needle insertion site - Known coagulopathy - Known allergy to local anesthetics - Presence of sensory or motor impairment in the distribution of the sciatic nerve prior to nerve blockade - Inability to perform valid sensory or motor examination of the function of the sciatic nerve prior to nerve blockade due to impaired access to the limb, language barrier, or inability of the subject to co-operate with such examination

Additional Information

Official title A Novel Approach to Reverse and Titrate the Clinical Effects of a Nerve Block
Description Background and rationale Peripheral nerve blocks provide effective surgical anesthesia targeted to specific body regions while avoiding the unpleasant side-effects of general anesthesia. Additionally, infusion of local anesthetic (LA) solution through a perineural catheter can provide superior analgesia compared to opioid painkillers and reduces the incidence of opioid-associated side effects. Most studies to date have focused on the efficacy of agents to extend block duration, thereby maximizing pain relief for patients receiving a nerve block. However, there are occasions when rapid and effective block reversal is needed. For example, interscalene brachial plexus block for upper extremity surgery frequently causes paralysis of the diaphragm due to inadvertent anesthesia of the phrenic nerve. A method to 'wash out' the local anesthetic around the phrenic nerve in these cases would be beneficial, especially for patients who have pre-existing pulmonary or respiratory diseases. Saline washout of LA may have an additional safety benefit since LAs are myotoxic; reducing the exposure of muscle to LA solutions while maintaining anesthesia would increase the safety of peripheral nerve blocks. Several studies have demonstrated that epidural washout using normal saline (NS) or Ringer's lactate following epidural block facilitates more rapid recovery of motor function and sensation than letting the block resolve on its own. However, no studies to date have addressed whether washout is effective for reversal of peripheral nerve blocks. Our limited clinical experience suggests that a bolus of NS through a perineural catheter can rapidly and effectively restore phrenic nerve function following interscalene block, and preliminary laboratory experiments indicate that a continuous washout of 0.9% NS reduces by half the time required for normal diaphragm function following injection of lidocaine around the phrenic nerve. Unclear, however, is the mechanism by which NS is able to resolve the block. Thus, the investigators wish to investigate the optimal approach to block reversal and resolution. Study objective To demonstrate that an infusion of NS can be used in a clinical setting to modify the properties of a nerve block in patients who have received a nerve block for surgery and post-operative analgesia. Hypothesis The investigators hypothesize that NS can be delivered through a perineural catheter to 'wash out' a nerve block to the point that motor function is restored while maintaining anesthesia of sensory nerve fibers. Procedure Using a sealed envelope system (see below), patients recruited to the study will be randomized to Control or Study groups. Baseline motor and sensory function will be assessed and recorded (see below for methods). Control group patients will undergo ultrasound-guided popliteal sciatic nerve block as described previously. A bolus of 20 mL 0.5% ropivacaine/0.5% bupivacaine will be delivered through a catheter-over-needle unit (e.g., B.Braun Contiplex C or equivalent) to provide surgical anesthesia to the lower extremity. After withdrawing the needle, the catheter will be left in place throughout the operation to provide a conduit to deliver rescue analgesia if required (see criteria below). Patients in the Study group will undergo the same procedures before and during surgery. After surgery, all patients will be brought to the recovery room for assessment of motor function and sensation in the anesthetized region. Study group patients will then receive a washout infusion regimen (e.g., continuous infusion of 3 mL per hour with a 3 mL bolus of 0.9% NS). Control group patients will receive an infusion of the same solution, but it will only be run at 1 mL/hr to maintain catheter patency. After the patient is transferred to the ward, motor and sensory assessment (see below) will be performed hourly until full motor function has returned. Once motor function has returned completely, the washout infusion will be stopped. The patient will be monitored for sensory function hourly for a maximum of 8 hours or until the first dose of oral pain medication or rescue analgesia is required. If the patient's pain score (determined by Numeric Rating Scale (NRS) score between 0-10, where 0 = no pain and 10 = worst pain ever) is >5, or if the patient is complaining of severe pain, the nerve block will be reinitiated by delivering a bolus of local anesthetic mixture through the catheter. A member of the clinical research team will follow up with the patient every 24 hours post-surgery (up to a maximum of 72 hours or discharge from hospital, whichever happens first) to record motor and sensory data and pain score. Sensory and motor assessment Sensory assessment will be performed by measuring current perception threshold (CPT) using the Neurometer (Neurotron, Inc., Baltimore, MD, USA), a validated device for sensory assessment. The investigators have experience using the Neurometer for CPT measurement and will be able to perform sensory assessment with the device easily and efficiently. Briefly, paired adhesive electrodes (Neotrode II, ConMed Corp., Utica, NY, USA) connected to the Neurometer will be attached to the big toe and the ankle of the leg that was blocked. The Neurometer can be set to three different frequencies - 2000 Hz, 250 Hz, and 5 Hz - that stimulate Aβ (large fiber/motor), Aδ (large fiber/pain), and C (small fiber/pain) fibers, respectively. A member of the research team will increase the current manually until the patient reports feeling an "electrical" sensation in the area where the electrodes are attached. The reading at this time will be recorded as the CPT. The data collector will also note if the current reached its maximum level, which will be defined as complete sensory blockade. Motor function will be assessed by recording voluntary motor responses in the lower extremity. The investigators will grade plantar flexion and dorsiflexion of the foot based on the following scale: 0 = normal movement, 1 = decreased movement, and 2 = no movement. Motor block will be deemed complete when a score of 2 is recorded for both plantar flexion and dorsiflexion. This grading scale has been described before for assessment of motor function following popliteal sciatic nerve block. Data recording and analysis The clinical research team member will record patient demographic information (age, height, weight, gender), NRS scores before and after surgery, and information about the nerve block and infusion regimen. This individual will also assess motor function and will assess sensory response (see above). Data will be recorded on a data sheet and transferred to an Excel spreadsheet for statistical analysis. Comparisons between groups will be performed with Student's t-test. Qualitative data will be reported as either absolute numbers or percentage and will be analyzed by Chi-square analysis or Fisher's exact test, whichever is appropriate. A p value of < 0.05 will be considered statistically significant. Sample size calculation The primary endpoint for this study will be time to return of full motor activity. Several reports have demonstrated that popliteal sciatic nerve block has an average duration of 14-16 hours. Our preliminary results of phrenic nerve block suggest that, following a bolus of washout solution, the time to recovery is reduced to approximately 50% versus time to spontaneous recovery. The investigators assume conservatively that 70% of Study group (washout) patients and 25% of Control group patients will have full motor activity with no pain by 8 hours. Using these parameters with an α value of 0.05 and β value of 0.2, it was determined that 19 patients per group (38 total) will be required to demonstrate a statistically significant difference. To compensate for study protocol violations and/or loss to follow-up, 20 patients will be recruited to each group (40 total). Randomization Prior to subject recruitment, a member of the study team not involved in data collection will create a series of 40 slips of paper indicating the allocation group (Study or Control) and the intervention (washout regimen or control (1 mL/hr infusion) regimen). The slips will be put into a random order and each placed in an opaque envelope. The envelopes will be sealed and numbered sequentially. During the study, once the patient returns to the post-anesthesia recovery room, the attending regional anesthesiologist will open the envelope to determine the intervention the patient is to receive. If this anesthesiologist is the PI, he will remove himself from the area while a colleague initiates the infusion. Blinding Both the investigators and participants will be blinded in this study. Investigators will be blinded by having one member of the study team collect the data and another study team member analyze the data. All study participants will have a nerve block catheter and be connected to an infusion pump; however, only Study group patients will receive the washout regimen. Control group patients will have the same solution running but at 1 mL/hr to maintain catheter patency. The pump display showing the infusion rate will be masked with tape or an opaque covering to prevent patients and data collectors from knowing the patient's allocation group.
Trial information was received from ClinicalTrials.gov and was last updated in December 2014.
Information provided to ClinicalTrials.gov by University of Alberta.